-
1
-
-
0037422456
-
Acyl glucuronide reactivity in perspective: Biological consequences
-
Bailey MJ and Dickinson RG. Acyl glucuronide reactivity in perspective: biological consequences. Chemico-Biological Interactions 2003; 145: 117-137.
-
(2003)
Chemico-Biological Interactions
, vol.145
, pp. 117-137
-
-
Bailey, M.J.1
Dickinson, R.G.2
-
3
-
-
54349100968
-
Pharmacokinetics, metabolism and excretion of torcetrapib in humans
-
Dalvie D, Chen W, Zhang C, Vaz AD, Smolarek TA, Cox LM, Lin J and Obach RS. Pharmacokinetics, metabolism and excretion of torcetrapib in humans. Drug Metabolism and Disposition 2008; 36: 2185-2198.
-
(2008)
Drug Metabolism and Disposition
, vol.36
, pp. 2185-2198
-
-
Dalvie, D.1
Chen, W.2
Zhang, C.3
Vaz, A.D.4
Smolarek, T.A.5
Cox, L.M.6
Lin, J.7
Obach, R.S.8
-
4
-
-
0021707968
-
Properties of acyl glucuronides: Implications for studies of the pharmacokinetics and metabolism of acidic drug
-
Faed EM. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drug. Drug Metabolism Reviews 1984; 15: 1213-1249.
-
(1984)
Drug Metabolism Reviews
, vol.15
, pp. 1213-1249
-
-
Faed, E.M.1
-
5
-
-
4143147349
-
Discovering drugs through biological transformation: Role of pharmacologically active metabolites in drug discovery
-
DOI 10.1021/jm040066v
-
Fura A, Shu Y, Zhu M, Hanson RL, Ronngta V and Humphreys WG. Discovering drugs through biological transformation: role of pharmacologically active metabolites in drug discovery. Journal of Medicinal Chemistry 2004; 47: 4339-4351. (Pubitemid 39096823)
-
(2004)
Journal of Medicinal Chemistry
, vol.47
, Issue.18
, pp. 4339-4351
-
-
Fura, A.1
Shu, Y.-Z.2
Zhu, M.3
Hanson, R.L.4
Roongta, V.5
Humphreys, W.G.6
-
6
-
-
85164047188
-
LC-MS in drug disposition and metabolism
-
Elsevier: Amsterdam
-
Hop CECA. LC-MS in drug disposition and metabolism. In The Encyclopedia of Mass Spectrometry. Elsevier: Amsterdam, 2006; 3: 233-274.
-
(2006)
The Encyclopedia of Mass Spectrometry
, vol.3
, pp. 233-274
-
-
Hop, C.E.C.A.1
-
7
-
-
19944399431
-
A comprehensive listing of bioactivation pathways of organic functional groups
-
DOI 10.2174/1389200054021799
-
Kalgutkar AS, Gardner I, Obach RS, Shaffer CL, Callegari E, Henne KR, Mutlib AE, Dalvie DK, Lee JS, Nakai Y, O'Donnell JP, Boer J and Harriman SP. A comprehensive listing of bioactivation pathways of organic functional groups. Current Drug Metabolism 2005; 6: 161-225. (Pubitemid 40753853)
-
(2005)
Current Drug Metabolism
, vol.6
, Issue.3
, pp. 161-225
-
-
Kalgutkar, A.S.1
Gardner, I.2
Obach, R.S.3
Shaffer, C.L.4
Callegari, E.5
Henne, K.R.6
Mutlib, A.E.7
Dalvie, D.K.8
Lee, J.S.9
Nakai, Y.10
O'Donnell, J.P.11
Boer, J.12
Harriman, S.P.13
-
8
-
-
0038375479
-
Drug-drug interactions: An important negative attribute in drugs
-
Obach RS. Drug-drug interactions: an important negative attribute in drugs. Drug Discovery Today 2003; 39: 301-338
-
(2003)
Drug Discovery Today
, vol.39
, pp. 301-338
-
-
Obach, R.S.1
-
9
-
-
52949118439
-
Metabolism, pharmacokinetics and excretion of a cholesterol ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: Characterization of unusual and novel metabolites by high-resoulution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance
-
Prakash C, Chen W, Rossulek M, Johnson K, Zhang C, O'Connell T, Potchoiba M and Dalvie D. Metabolism, pharmacokinetics and excretion of a cholesterol ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resoulution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance. Drug Metabolism and Disposition 2008; 36: 2064-2079.
-
(2008)
Drug Metabolism and Disposition
, vol.36
, pp. 2064-2079
-
-
Prakash, C.1
Chen, W.2
Rossulek, M.3
Johnson, K.4
Zhang, C.5
O'Connell, T.6
Potchoiba, M.7
Dalvie, D.8
-
14
-
-
33645533680
-
Ultra-low flow nanospray for the normalization of conventional LC/MS through equimolar response: Standard-free quantitative estimation of metabolite levels in drug discovery
-
Valaskovic GA, Utley L, Lee MS and Wu JT. Ultra-low flow nanospray for the normalization of conventional LC/MS through equimolar response: standard-free quantitative estimation of metabolite levels in drug discovery. Rapid Communications in Mass Spectrumetry 2006; 20(7): 1087-196.
-
(2006)
Rapid Communications in Mass Spectrumetry
, vol.20
, Issue.7
, pp. 1087-1196
-
-
Valaskovic, G.A.1
Utley, L.2
Lee, M.S.3
Wu, J.T.4
|